Navigation Links
Pathwork(R) Diagnostics Launches Genomics-Based Test For Hard-To-Identify Tumors Through Its CLIA-Certified Laboratory
Date:4/22/2008

The Pathwork(R) Tissue of Origin Test Aids in the Diagnosis of Uncertain

Tumors

SUNNYVALE, Calif., April 22 /PRNewswire/ -- Pathwork Diagnostics, Inc., a genomics-based diagnostics company focused on oncology, today announced the launch of the Pathwork Tissue of Origin Test through its CLIA-certified Pathwork(R) Diagnostics Laboratory. The new test aids in the diagnosis of tumors of uncertain origin and is among the first microarray-based diagnostic tests for cancer available in the United States.

"The Pathwork Tissue of Origin Test uses the power of genomic information to provide diagnostic answers that help physicians make clinical decisions with more certainty. Ultimately, we believe our test will improve patient outcomes while saving the healthcare system money," said Deborah J. Neff, president and chief executive officer of Pathwork Diagnostics. "We are making our test available through our clinical laboratory due to strong interest from leading oncologists and pathologists. We are also working actively with the FDA to obtain product clearance, so that we can offer a diagnostic kit directly to clinical laboratories at major medical centers."

The Pathwork Tissue of Origin Test measures the expression of more than 1,500 genes to compare a tumor's gene expression profile to those of 15 known tissues, representing more than 60 morphologies, and to provide an objective, probability-based score for each potential tissue. The test uses a proprietary Pathchip(TM) microarray and runs on the proven Affymetrix GeneChip(R) System. In a Pathwork Diagnostics Laboratory clinical validation study of 487 metastatic and poorly differentiated and undifferentiated tumors, which had already been identified using current methodologies, the test demonstrated a sensitivity of 89 percent and a specificity of 99 percent.(1)

"Hard-to-identify tumors are a significant clinical problem," said Divyesh D. Mehta, M.D., Dire
'/>"/>

SOURCE Pathwork Diagnostics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance
2. Roche Molecular Diagnostics Invests $57.5 Million in Green Research Building
3. Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research
4. Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo
5. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
6. Dr. Linda McAllister Joins Arbor Vita Corporation as Vice President of Diagnostics
7. Quest Diagnostics to Speak at Cowen and Company 28th Annual Health Care Conference
8. Quest Diagnostics to Speak at Lehman Brothers 11th Annual Global Healthcare Conference
9. BioMagnetics Diagnostics Corp. Rated Speculative Buy, Target Price $1.42 by Beacon Equity Research
10. The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
11. Quest Diagnostics Named to FORTUNE Magazines Americas Most Admired Companies List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015 S&P Capital IQ (MHFI) announced ... coverage on MabVax Therapeutics Holdings Inc . ... stage biotechnology company focused on the development of vaccine ... the treatment of cancer. MabVax has discovered a pipeline ... immune responses generated by patients who have been immunized ...
(Date:2/26/2015)... 26, 2015  23andMe, the leading personal genetics company, ... as Privacy Officer and Corporate Counsel. Black brings a ... as well as health care regulations. As a member ... responsible for reviewing, updating and enhancing the company,s privacy ... abroad. She joined the company January 5, 2015 and ...
(Date:2/26/2015)... Synageva BioPharma Corp. (NASDAQ: GEVA ... rare disorders, today reported 2014 full year financial ... and financial guidance.  Synageva,s management team will host ... to review the financial results and provide a ... by telephone, please dial (877) 445-4603 for U.S. ...
(Date:2/26/2015)... PARK, Calif. , Feb. 26, 2015 ... released the latest version of the Governance Portal ... accomplish governance, risk and compliance (GRC) tasks across multiple ... also been updated to help customers better align their ... of the Treadway Commission ) requirements. In response to ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 523andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
... (Nasdaq: OREX ), a biopharmaceutical company focused on ... third quarter of 2011. For the three months ended September ... or $0.10 per share, as compared to a net loss ... quarter of 2010. As of September 30, 2011, Orexigen had ...
... an open-source, web-based platform for data-intensive biomedical and ... "cloud computing" resource. A team of researchers including ... molecular biology at Penn State University; Kateryna Makova, ... and James Taylor from Emory University, developed the ...
... plastics could be produced using an intricate chemical process ... 80,000 times smaller than a hair,s breadth ... could give materials exceptional versatility. By weaving threads ... at the University of Edinburgh have created the building ...
Cached Biology Technology:Orexigen® Therapeutics Reports Third Quarter Financial Results 2Orexigen® Therapeutics Reports Third Quarter Financial Results 3Orexigen® Therapeutics Reports Third Quarter Financial Results 4Orexigen® Therapeutics Reports Third Quarter Financial Results 5Galaxy DNA-analysis software is now available 'in the cloud' 2Galaxy DNA-analysis software is now available 'in the cloud' 3Tying atomic threads in knots may produce material benefits 2
(Date:2/24/2015)... , Feb. 24, 2015 Research and ... the addition of the "Global 2D Gesture ... The analysts forecast the Global ... CAGR of 32.12% over the period 2014-2019 ... in non-traditional sectors is one of the major ...
(Date:2/19/2015)... DUBLIN , Feb .19, 2015 Research ... announced the addition of the "Military Electro-Optical ... by Sensor Technology, by Platform - Forecast to ... The military electro-optical/infrared systems market is expected ... a CAGR of 7.71%. This report ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3ACT Genomics Raises $8 Million in its First Private Funding Round 2
... a soft spot for Botswana, developed while reading the ... had a chance to do any sleuthing of their ... University of Illinois scientist Karen Chapman-Novakofski acquired a Batswana ... the health and nutrition of that country,s elderly. ...
... pathologists have identified a new molecular target that one ... transport to adipocytes (fat cells) in the body and ... Detailed in the Oct. 18 online edition and the ... Investigation, the findings about a specific cell receptor, known ...
... expression patterns in zebrafish embryos resulting from exposure to ... according to research published in the online open access ... zebrafish to each toxin can be read like a ... effects of the toxin on developing vertebrate embryos. ...
Cached Biology News:U of I scientist does nutritional detective work in Botswana 2U of I scientist does nutritional detective work in Botswana 3'Knocking out' cell receptor may help block fat deposits in tissues, prevent weight gain 2Decoding effects of toxins on embryo development 2
...
... The organic acid analysis ... of six organic salts; molecular ... 294. This standard is provided ... HPX-87H column and the organic ...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds....
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential GI liabilities of compounds....
Biology Products: